Why Is Global Transradial Access Devices Market Expanding Rapidly?
The high prevalence of chronic diseases, burgeoning requirement for chemotherapy procedures, growing use of radial access devices on geriatric and high-risk patients, and surging healthcare expenditure are the key transradial access devices market growth drivers. The transradial approach benefits from low cost and favorable clinical outcomes over transfemoral interventions; therefore, it can help in reducing the healthcare expense for patients, especially in developing countries. Thus, with the growing volume of catheterization procedures, the demand for the devices used for accessing the targeted tissue via the radial artery will increase.
Various studies have been conducted to determine the benefits of using the transradial approach for transarterial chemoembolization in cancer patients. The favorable results of these studies are boosting the preference for this approach, thereby propelling the growth of the transradial access devices market. Those with peripheral vascular diseases, patients on oral anticoagulants who have a high risk of vascular access site bleeding, elderly patients, and morbidly obese patients are treated by snaking a catheter to the targeted therapy site via the radial artery, which runs through the arm.
In this regard, the growing volume of embolotherapy procedures can be considered a key transradial access devices market growth driver. Such procedures are widely conducted for the treatment of cancer, arteriovenous malformations, cerebral aneurysms, and gastroenterological, nephrological, and urological disorders. They involve administering an embolic agent to the targeted tissue in order to cut its blood supply and lead to cell death. Moreover, microspheres can be placed at the targeted tissue via transradial catheterization to inject drugs.
Geographically, Europe contributed the highest revenue to the transradial access devices market in the past. This was due to the wide acceptance of transradial intervention (TRI) as the default strategy for percutaneous coronary interventions (PCI) in Europe. Moreover, the U.S., Canada, China, India, and Japan are expected to create a high demand for transradial access devices in the coming years. The advancing healthcare infrastructure and rising awareness among various healthcare providers regarding the benefits of the transradial approach over the transfemoral approach are propelling the market.
Therefore, the demand for transradial access devices will increase due to the changing preferences of healthcare providers and increasing prevalence of chronic diseases globally.
Get More Details Transradial Access Devices Market In-Depth Regional Analysis
